A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The management of childhood infections remains inadequate in resource-limited countries, resulting in high mortality and irrational use of antimicrobials. Current disease management tools, such as the Integrated Management of Childhood Illness (IMCI) algorithm, rely solely on clinical signs and have not made use of available point-of-care tests (POCTs) that can help to identify children with severe infections and children in need of antibiotic treatment. e-POCT is a novel electronic algorithm based on current evidence; it guides clinicians through the entire consultation and recommends treatment based on a few clinical signs and POCT results, some performed in all patients (malaria rapid diagnostic test, hemoglobin, oximeter) and others in selected subgroups only (C-reactive protein, procalcitonin, glucometer). The objective of this trial was to determine whether the clinical outcome of febrile children managed by the e-POCT tool was non-inferior to that of febrile children managed by a validated electronic algorithm derived from IMCI (ALMANACH), while reducing the proportion with antibiotic prescription. METHODS AND FINDINGS: We performed a randomized (at patient level, blocks of 4), controlled non-inferiority study among children aged 2-59 months presenting with acute febrile illness to 9 outpatient clinics in Dar es Salaam, Tanzania. In parallel, routine care was documented in 2 health centers. The primary outcome was the proportion of clinical failures (development of severe symptoms, clinical pneumonia on/after day 3, or persistent symptoms at day 7) by day 7 of follow-up. Non-inferiority would be declared if the proportion of clinical failures with e-POCT was no worse than the proportion of clinical failures with ALMANACH, within statistical variability, by a margin of 3%. The secondary outcomes included the proportion with antibiotics prescribed on day 0, primary referrals, and severe adverse events by day 30 (secondary hospitalizations and deaths). We enrolled 3,192 patients between December 2014 and February 2016 into the randomized study; 3,169 patients (e-POCT: 1,586; control [ALMANACH]: 1,583) completed the intervention and day 7 follow-up. Using e-POCT, in the per-protocol population, the absolute proportion of clinical failures was 2.3% (37/1,586), as compared with 4.1% (65/1,583) in the ALMANACH arm (risk difference of clinical failure -1.7, 95% CI -3.0, -0.5), meeting the prespecified criterion for non-inferiority. In a non-prespecified superiority analysis, we observed a 43% reduction in the relative risk of clinical failure when using e-POCT compared to ALMANACH (risk ratio [RR] 0.57, 95% CI 0.38, 0.85, p = 0.005). The proportion of severe adverse events was 0.6% in the e-POCT arm compared with 1.5% in the ALMANACH arm (RR 0.42, 95% CI 0.20, 0.87, p = 0.02). The proportion of antibiotic prescriptions was substantially lower, 11.5% compared to 29.7% (RR 0.39, 95% CI 0.33, 0.45, p < 0.001). Using e-POCT, the most common indication for antibiotic prescription was severe disease (57%, 103/182 prescriptions), while it was non-severe respiratory infections using the control algorithm (ALMANACH) (70%, 330/470 prescriptions). The proportion of clinical failures among the 544 children in the routine care cohort was 4.6% (25/544); 94.9% (516/544) of patients received antibiotics on day 0, and 1.1% (6/544) experienced severe adverse events. e-POCT achieved a 49% reduction in the relative risk of clinical failure compared to routine care (RR 0.51, 95% CI 0.31, 0.84, p = 0.007) and lowered antibiotic prescriptions to 11.5% from 94.9% (p < 0.001). Though this safety study was an important first step to evaluate e-POCT, its true utility should be evaluated through future implementation studies since adherence to the algorithm will be an important factor in making use of e-POCT's advantages in terms of clinical outcome and antibiotic prescription. CONCLUSIONS: e-POCT, an innovative electronic algorithm using host biomarker POCTs, including C-reactive protein and procalcitonin, has the potential to improve the clinical outcome of children with febrile illnesses while reducing antibiotic use through improved identification of children with severe infections, and better targeting of children in need of antibiotic prescription. TRIAL REGISTRATION: ClinicalTrials.gov NCT02225769.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, L., Oza, S., Hogan, D., Perin, J., Rudan, I., Lawn, J. E., Cousens, S., Mathers, C., & Black, R. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61698-6 · Cited by 3,167 · cited 1×
“However, correct identification of this minority of children is pivotal; substandard management of children with infections has led to 2 major public health challenges: first, persistent high mortality from common childhood infections [3] and, second, the tremendous overprescription of antibiotics at the peripheral he…”
BackgroundAntimicrobial resistance in developing countries. Part I: recent trends and current status
Okeke, I. N., Laxminarayan, R., Bhutta, Z. A., Duse, A. G., Jenkins, P., O'Brien, T. F., Pablos-Mendez, A., & Klugman, K. P. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70189-4 · Cited by 851 · cited 1×
“However, correct identification of this minority of children is pivotal; substandard management of children with infections has led to 2 major public health challenges: first, persistent high mortality from common childhood infections [3] and, second, the tremendous overprescription of antibiotics at the peripheral he…”
BackgroundAn Analysis of Anemia and Child Mortality
Brabin, B. J., Premji, Z., & Verhoeff, F. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.2.636s · Cited by 319
Church, J., & Maitland, K. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-31 · Cited by 203
Hazir, T., Nisar, Y. B., Abbasi, S., Ashraf, Y. P., Khurshid, J., Tariq, P., Asghar, R., Murtaza, A., Masood, T., & Maqbool, S. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq142 · Cited by 101 · cited 1×
“The criteria used to define clinical failure were based on previous pneumonia management trials [23,24].”
Method
Cited by
The effects of on-screen, point of care computer reminders on processes and outcomes of care
Shojania, K. G., Jennings, A., Ramsay, C. R., Grimshaw, J. M., Kwan, J. L., & Lo, L. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001096.pub2 · Cited by 466
Keitel, K., & D'Acremont, V. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.04.014 · Cited by 79
Self-citationSarrassat, S., Lewis, J. J., Some, A. S., Somda, S., Cousens, S., & Blanchet, K. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-06317-3 · Cited by 61
Pellé, K. G., Rambaud-Althaus, C., D'Acremont, V., Moran, G., Sampath, R., Katz, Z., Moussy, F. G., Mehl, G. L., & Dittrich, S. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2019-002067 · Cited by 51
Self-citation
Metadata
- Authors
- Keitel, K., Kagoro, F., Samaka, J., Masimba, J., Said, Z., Temba, H., Mlaganile, T., Sangu, W., Rambaud-Althaus, C., Gervaix, A., Genton, B., & D’Acremont, V.
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-10-23
- Volume
- 14
- Issue
- 10
- Pages
- e1002411
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- OpenAlex
- W2766539018
- Cited by
- 142
- References
- 5
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial. https://app.cochat.ai/papers/10.1371/journal.pmed.1002411
- The paper
- Keitel, K., Kagoro, F., Samaka, J., Masimba, J., Said, Z., Temba, H., Mlaganile, T., Sangu, W., Rambaud-Althaus, C., Gervaix, A., Genton, B., & D’Acremont, V. (2017). A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1002411
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.